News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
334 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18555)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (201)
2 (268)
3 (272)
4 (305)
5 (108)
6 (6)
7 (10)
8 (235)
9 (334)
10 (239)
11 (333)
12 (116)
13 (2)
14 (3)
15 (255)
16 (204)
17 (173)
18 (167)
19 (88)
20 (9)
21 (8)
22 (183)
23 (215)
24 (191)
25 (218)
26 (104)
28 (2)
29 (12)
30 (225)
31 (296)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
28
29
30
31
Business
Novanta Announces Financial Results for the First Quarter 2023
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2023.
May 9, 2023
·
29 min read
Business
Seres Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
Seres Therapeutics, Inc., a leading microbiome therapeutics company, reported first quarter 2023 financial results and provided business updates.
May 9, 2023
·
17 min read
Business
908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook
908 Devices Inc. today reported financial results for the quarter ended March 31, 2023.
May 9, 2023
·
7 min read
Business
Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
Spectrum Pharmaceuticals, Inc. announced today financial results for the three-month period ended March 31, 2023, and provided a corporate update.
May 9, 2023
·
19 min read
Genetown
Vedanta Biosciences to Participate in the JMP Securities Life Sciences Conference - May 9, 2023
Vedanta Biosciences today announced that management will participate in a fireside chat and host investor meetings at the JMP Securities Life Sciences Conference being held May 15-16, 2023 at the New York Hilton Midtown in New York, NY.
May 9, 2023
·
1 min read
Business
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
Precision BioSciences, Inc. today announced financial results for the first quarter ended March 31, 2023 and provided a business update.
May 9, 2023
·
15 min read
Lone Star Bio
Coya Therapeutics, Inc. to Present at the Sidoti Virtual Investor Conference on Thursday, May 11, 2023, at 2:30pm ET
Coya Therapeutics, Inc. today announced management will present at the Sidoti Virtual Investor Conference Thursday May 11 at 2:30pm ET.
May 9, 2023
·
5 min read
FDA
Rocket Pharmaceuticals Announces FDA Clearance of IND for Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
Rocket Pharmaceuticals, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Company’s Investigational New Drug (IND) application for RP-A601.
May 9, 2023
·
9 min read
Pharm Country
Arbutus to Present at JMP Securities Life Sciences Conference 2023
Arbutus Biopharma Corporation announced that the Company will participate in a fireside chat at the JMP Securities Life Sciences Conference taking place in New York on Tuesday, May 16, 2023 at 9:00 am ET.
May 9, 2023
·
1 min read
Business
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, reported its first quarter 2023 financial results and highlighted recent operational achievements as the Company accelerates XOMA’s differentiated biotech royalty and milestone acquisition strategy.
May 9, 2023
·
11 min read
Previous
26 of 34
Next